Active Biotech AB Share Price Xetra
Equities
BTPC
SE0001137985
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Sales 2024 * | - | Sales 2025 * | 15.6M 1.47M 1.35M 123M | Capitalization | 178M 16.83M 15.44M 1.41B |
---|---|---|---|---|---|
Net income 2024 * | -42M -3.97M -3.64M -331M | Net income 2025 * | -35M -3.31M -3.03M -276M | EV / Sales 2024 * | - |
Net Debt 2024 * | 6.5M 614K 563K 51.26M | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 11.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.39% |
Managers | Title | Age | Since |
---|---|---|---|
Helén Tuvesson
CEO | Chief Executive Officer | 62 | 01/98/01 |
Hans Kolam
DFI | Director of Finance/CFO | 73 | 01/00/01 |
Erik Vahtola
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 23/19/23 |
Director/Board Member | 50 | 01/20/01 | |
Michael Shalmi
CHM | Chairman | 59 | 23/19/23 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- ACTI Stock
- BTPC Stock